Genetic variants and animal models in SNCA and Parkinson disease
- 1 May 2014
- journal article
- review article
- Published by Elsevier in Ageing Research Reviews
- Vol. 15, 161-176
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81101339, 81271921)
- Fundamental Research Funds for the Central Universities (2011JQ014)
- Fundamental Research Funds for Central Universities of the Central South University (2013zzts101)
- Specialized Research Fund for the Doctoral Program of Higher Education of China (20110162110026)
This publication has 233 references indexed in Scilit:
- Somatic alpha‐synuclein mutations in Parkinson's disease: Hypothesis and preliminary dataMovement Disorders, 2013
- Inclusion of a portion of the native SNCA 3′UTR reduces toxicity of human S129A SNCA on striatal‐projecting dopamine neurons in rat substantia NigraDevelopmental Neurobiology, 2011
- Replication of MAPT and SNCA, but not PARK16‐18, as susceptibility genes for Parkinson's diseaseMovement Disorders, 2011
- SNCA Variant Associated With Parkinson Disease and Plasma α-Synuclein LevelArchives of Neurology, 2010
- Independent and joint effects of the MAPT and SNCA genes in Parkinson diseaseAnnals of Neurology, 2010
- Frequency of Known Mutations in Early-Onset Parkinson DiseaseArchives of Neurology, 2010
- Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation updateHuman Mutation, 2010
- Alpha‐synuclein and familial Parkinson's diseaseMovement Disorders, 2009
- Familial Parkinsonism and early onset Parkinson's disease in a Brazilian movement disorders clinic: Phenotypic characterization and frequency of SNCA, PRKN, PINK1, and LRRK2 mutationsMovement Disorders, 2009
- The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementiaAnnals of Neurology, 2003